Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Novel therapies for children with severe asthma
Top Ten Searches
hla beta 2 probiotics hypo allergenic scid urticaria aeroallergens asthma angioedema hivYour Article Summary
Evaluation of airway hyperresponsiveness and exhaled nitric oxide as risk factors for airway remodeling in patients with stable asthma
Allergy and Asthma Proceedings, 09/09/09
Ohkura N et al. – Adjusted deltaFEV1/year did not correlate with eNO measured during the second observation period or methacholine PC20 measured during the first observation period. On the other hand, methacholine PC20 measured during the latter period was correlated significantly with adjusted deltaFEV1/year. Persistent AHR may be a risk factor for longitudinal decline in FEV1 in asthma patients even if their asthma is stable and well controlled by inhaled corticosteroid.
Today in Cardiovascular/Pulm...keeping you current
Receive free subspecialty "5-minute updates" via email
Role of adenoids and adenoiditis in children with allergy and otitis media
Current Allergy and Asthma Reports, 10/22/09
Montelukast in the treatment of asthma and beyond
Expert Review of Clinical Immunology, 11/23/09
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09
Sponsor
Article Search
Sponsor


See Latest Articles


